Implications of glial nitric oxide in neurodegenerative diseases

Frontiers in Cellular Neuroscience

Volumn 9, Issue AUGUST, 2015, Pages

  Yuste, Jose Enrique ^a   Tarragon, Ernesto ^a,b   Campuzano, Carmen María ^a   Ros Bernal, Francisco ^a  

^a UNIVERSITAT JAUME I   (Spain)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Neurodegenerative disorders; Neuroinflammation; Neuronal death; Neuronal nitric oxide; Nitric oxide

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC GMP; CYTOKINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; GUANYLATE CYCLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MONOCARBOXYLATE TRANSPORTER 1; NEUROTRANSMITTER; NICOTINAMIDE ADENINE DINUCLEOTIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PHOSPHODIESTERASE; PRESENILIN 1; PROSTAGLANDIN SYNTHASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; STROMAL CELL DERIVED FACTOR 1; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CELL ACTIVATION; DEGENERATIVE DISEASE; DEMYELINATION; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; EXCITOTOXICITY; HUMAN; LIPID PEROXIDATION; MICROGLIA; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; MULTIPLE SCLEROSIS; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; REVIEW; SIGNAL TRANSDUCTION;

EID: 84940213599     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00322     Document Type: Review

References (160)

1. Abe, K., Pan, L. H., Watanabe, M., Kato, T., and Itoyama, Y. (1995). Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis. Neurosci. Lett. 199, 152-154. doi: 10.1016/0304-3940(95)12039-7
2. Abe, K., Pan, L. H., Watanabe, M., Konno, H., Kato, T., and Itoyama, Y. (1997). Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis. Neurol. Res. 19, 124-128.
3. Agar, J., and Durham, H. (2003). Relevance of oxidative injury in the pathogenesis of motor neuron diseases. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 4, 232-242. doi: 10.1080/14660820310011278
4. Alderton, W. K., Cooper, C. E., and Knowles, R. G. (2001). Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357, 593-615. doi: 10.1042/0264-6021:3570593
5. AlFadhli, S., Mohammed, E. M., and Al Shubaili, A. (2013). Association analysis of nitric oxide synthases: NOS1, NOS2A and NOS3 genes, with multiple sclerosis. Ann. Hum. Biol. 40, 368-375. doi: 10.3109/03014460.2013.786756
6. Bagasra, O., Michaels, F. H., Zheng, Y. M., Bobroski, L. E., Spitsin, S. V., Fu, Z. F., et al. (1995). Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. U S A 92, 12041-12045. doi: 10.1073/pnas.92.26.12041
7. Bales, K. R., Du, Y., Holtzman, D., Cordell, B., and Paul, S. M. (2000). Neuroinflammation and alzheimer's disease: critical roles for cytokine/Abeta-induced glial activation, NF-kappaB and apolipoprotein E. Neurobiol. Aging 21, 427-432; discussion 451-423. doi: 10.1016/s0197-4580(00)00143-3
8. Balligand, J. L., Kelly, R. A., Marsden, P. A., Smith, T. W., and Michel, T. (1993). Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. U S A 90, 347-351. doi: 10.1073/pnas.90.1.347
9. Bal-Price, A., and Brown, G. C. (2001). Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci. 21, 6480-6491.
10. Bamberger, M. E., Harris, M. E., McDonald, D. R., Husemann, J., and Landreth, G. E. (2003). A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J. Neurosci. 23, 2665-2674.
11. Bamford, N. S., Robinson, S., Palmiter, R. D., Joyce, J. A., Moore, C., and Meshul, C. K. (2004). Dopamine modulates release from corticostriatal terminals. J. Neurosci. 24, 9541-9552. doi: 10.1523/jneurosci.2891-04.2004
12. Barcia, C., Sánchez Bahillo, A., Fernández-Villalba, E., Bautista, V., Poza, Y. P. M., Fernández-Barreiro, A., et al. (2004). Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure. Glia 46, 402-409. doi: 10.1002/glia.20015
13. Beal, M. F. (1998). Excitotoxicity and nitric oxide in parkinson's disease pathogenesis. Ann. Neurol. 44, S110-S114. doi: 10.1002/ana.410440716
14. Beal, M. F. (2002). Oxidatively modified proteins in aging and disease. Free Radic. Biol. Med. 32, 797-803. doi: 10.1016/s0891-5849(02)00780-3
15. Beckman, J. S., Chen, J., Crow, J. P., and Ye, Y. Z. (1994). Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. Prog. Brain Res. 103, 371-380. doi: 10.1016/s0079-6123(08)61151-6
16. Beckman, J. S., and Crow, J. P. (1993). Pathological implications of nitric oxide, superoxide and peroxynitrite formation.Biochem. Soc. Trans. 21, 330-334. doi: 10.1042/bst0210330
17. Beckman, J. S., and Esteves, A. G. (2006). "Superoxide dismutase, oxidative stress and ALS," in Amyotrophic Lateral Sclerosis, eds H. Mitsumoto, S. Perzedborski, and P. H. Gordon (New York: Taylor & Francis Group), 339-354.
18. Benhar, M., Forrester, M. T., Hess, D. T., and Stamler, J. S. (2008). Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science 320, 1050-1054. doi: 10.1126/science.1158265
19. Benner, E. J., Banerjee, R., Reynolds, A. D., Sherman, S., Pisarev, V. M., Tsiperson, V., et al. (2008). Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons. PLoS One 3:e1376. doi: 10.1371/journal.pone.0001376
20. Bhaskaran, D., and Radha, E. (1983). Monoamine levels and monoamine oxidase activity in different regions of rat brain as a function of age. Mech. Ageing Dev. 23, 151-160. doi: 10.1016/0047-6374(83)90064-7
21. Boll, M. C., Alcaraz-Zubeldia, M., Montes, S., Murillo-Bonilla, L., and Rios, C. (2003). Raised nitrate concentration and low SOD activity in the CSF of sporadic ALS patients. Neurochem. Res. 28, 699-703. doi: 10.1023/A:1022853531855
22. Brambilla, R., Persaud, T., Hu, X., Karmally, S., Shestopalov, V. I., Dvoriantchikova, G., et al. (2009). Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J. Immunol. 182, 2628-2640. doi: 10.4049/jimmunol.0802954
23. Bredt, D. S., Hwang, P. M., and Snyder, S. H. (1990). Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347, 768-770. doi: 10.1038/347768a0
24. Brosnan, C. F., Battistini, L., Raine, C. S., Dickson, D. W., Casadevall, A., and Lee, S. C. (1994). Reactive nitrogen intermediates in human neuropathology: an overview. Dev. Neurosci. 16, 152-161. doi: 10.1159/000112102
25. Brown, G. C. (2007). Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem. Soc. Trans. 35, 1119-1121. doi: 10.1042/bst0351119
26. Bruijn, L. I., Beal, M. F., Becher, M. W., Schulz, J. B., Wong, P. C., Price, D. L., et al. (1997). Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proc. Natl. Acad. Sci. U S A 94, 7606-7611. doi: 10.1073/pnas.94.14.7606
27. Calabrese, V., Mancuso, C., Calvani, M., Rizzarelli, E., Butterfield, D. A., and Stella, A. M. (2007). Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci. 8, 766-775. doi: 10.1038/nrn2214
28. Calderon, T. M., Eugenin, E. A., Lopez, L., Kumar, S. S., Hesselgesser, J., Raine, C. S., et al. (2006). A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein. J. Neuroimmunol. 177, 27-39. doi: 10.1016/j.jneuroim.2006.05.003
29. Cao, J., Viholainen, J. I., Dart, C., Warwick, H. K., Leyland, M. L., and Courtney, M. J. (2005). The PSD95-nNOS interface: a target for inhibition of excitotoxic p38 stress-activated protein kinase activation and cell death. J. Cell Biol. 168, 117-126. doi: 10.1083/jcb.200407024
30. Casoni, F., Basso, M., Massignan, T., Gianazza, E., Cheroni, C., Salmona, M., et al. (2005). Protein nitration in a mouse model of familial amyotrophic lateral sclerosis: possible multifunctional role in the pathogenesis. J. Biol. Chem. 280, 16295-16304. doi: 10.1074/jbc.m413111200
31. Cassina, P., Peluffo, H., Pehar, M., Martinez-Palma, L., Ressia, A., Beckman, J. S., et al. (2002). Peroxynitrite triggers a phenotypic transformation in spinal cord astrocytes that induces motor neuron apoptosis. J. Neurosci. Res. 67, 21-29. doi: 10.1002/jnr.10107
32. Cetin, F., Yazihan, N., Dincer, S., and Akbulut, K. G. (2013). The effect of intracerebroventricular injection of beta amyloid peptide (1-42) on caspase 3 activity, lipid peroxidation and NOS expression in young adult and aged rat brain. Turk. Neurosurg. 23, 144-150. doi: 10.5137/1019-5149.JTN.5855-12.1
33. Chabrier, P. E., Demerlé-Pallardy, C., and Auguet, M. (1999). Nitric oxide synthases: targets for therapeutic strategies in neurological diseases. Cell. Mol. Life Sci. 55, 1029-1035. doi: 10.1007/s000180050353
34. Chang, Y. C., Kim, H. W., Rapoport, S. I., and Rao, J. S. (2008). Chronic NMDA administration increases neuroinflammatory markers in rat frontal cortex: cross-talk between excitotoxicity and neuroinflammation. Neurochem. Res. 33, 2318-2323. doi: 10.1007/s11064-008-9731-8
35. Chattopadhyay, M., Goswami, S., Rodes, D. B., Kodela, R., Velazquez, C. A., Boring, D., et al. (2010). NO-releasing NSAIDs suppress NF-kappaB signaling in vitro and in vivo through S-nitrosylation. Cancer Lett. 298, 204-211. doi: 10.1016/j.canlet.2010.07.006
36. Cho, D. H., Nakamura, T., Fang, J., Cieplak, P., Godzik, A., Gu, Z., et al. (2009). S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 324, 102-105. doi: 10.1126/science.1171091
37. Chung, K. K., Thomas, B., Li, X., Pletnikova, O., Troncoso, J. C., Marsh, L., et al. (2004). S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 304, 1328-1331. doi: 10.1126/science.1093891
38. Colombo, E., Cordiglieri, C., Melli, G., Newcombe, J., Krumbholz, M., Parada, L. F., et al. (2012). Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration. J. Exp. Med. 209, 521-535. doi: 10.1084/jem.20110698
39. Conwit, R. A. (2006). Preventing familial ALS: a clinical trial may be feasible but is an efficacy trial warranted? J. Neurol. Sci.251, 1-2. doi: 10.1016/j.jns.2006.07.009
40. Cookson, M. R., Menzies, F. M., Manning, P., Eggett, C. J., Figlewicz, D. A., McNeil, C. J., et al. (2002). Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 3, 75-85. doi: 10.1080/146608202760196048
41. Cookson, M. R., and Shaw, P. J. (1999). Oxidative stress and motor neurone disease. Brain Pathol. 9, 165-186. doi: 10.1111/j.1750-3639.1999.tb00217.x
42. da Costa, C. A., Sunyach, C., Giaime, E., West, A., Corti, O., Brice, A., et al. (2009). Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile parkinson's disease. Nat. Cell Biol. 11, 1370-1375. doi: 10.1038/ncb1981
43. D'Amico, E., Factor-Litvak, P., Santella, R. M., and Mitsumoto, H. (2013). Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radic. Biol. Med. 65C, 509-527. doi: 10.1016/j.freeradbiomed.2013.06.029
44. Danielson, S. R., and Andersen, J. K. (2008). Oxidative and nitrative protein modifications in parkinson's disease. Free Radic. Biol. Med. 44, 1787-1794. doi: 10.1016/j.freeradbiomed.2008.03.005
45. Dauer, W., and Przedborski, S. (2003). Parkinson's disease: mechanisms and models. Neuron 39, 889-909. doi: 10.1016/S0896-6273(03)00568-3
46. Davis, R. L., Sanchez, A. C., Lindley, D. J., Williams, S. C., and Syapin, P. J. (2005). Effects of mechanistically distinct NF-kappaB inhibitors on glial inducible nitric-oxide synthase expression. Nitric Oxide 12, 200-209. doi: 10.1016/j.niox.2005.04.005
47. Dobos, N., Korf, J., Luiten, P. G., and Eisel, U. L. (2010). Neuroinflammation in alzheimer's disease and major depression. Biol. Psychiatry 67, 503-504. doi: 10.1016/j.biopsych.2010.01.023
48. Doorduin, J., De Vries, E. F., Willemsen, A. T., De Groot, J. C., Dierckx, R. A., and Klein, H. C. (2009). Neuroinflammation in schizophrenia-related psychosis: a PET study. J. Nucl. Med. 50, 1801-1807. doi: 10.2967/jnumed.109.066647
49. Duda, J. E., Giasson, B. I., Chen, Q., Gur, T. L., Hurtig, H. I., Stern, M. B., et al. (2000). Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies. Am. J. Pathol. 157, 1439-1445. doi: 10.1016/s0002-9440(10)64781-5
50. Duncan, A. J., and Heales, S. J. (2005). Nitric oxide and neurological disorders. Mol. Aspects Med. 26, 67-96. doi: 10.1016/j.mam.2004.09.004
51. Estévez, A. G., Spear, N., Thompson, J. A., Cornwell, T. L., Radi, R., Barbeito, L., et al. (1998). Nitric oxide-dependent production of cGMP supports the survival of rat embryonic motor neurons cultured with brain-derived neurotrophic factor. J. Neurosci. 18, 3708-3714.
52. Eu, J. P., Sun, J., Xu, L., Stamler, J. S., and Meissner, G. (2000). The skeletal muscle calcium release channel: coupled O2 sensor and NO signaling functions. Cell 102, 499-509. doi: 10.1016/s0092-8674(00)00054-4
53. Ferrer, M. D., Sureda, A., Mestre, A., Tur, J. A., and Pons, A. (2010). The double edge of reactive oxygen species as damaging and signaling molecules in HL60 cell culture. Cell. Physiol. Biochem. 25, 241-252. doi: 10.1159/000276558
54. Frank-Cannon, T. C., Alto, L. T., McAlpine, F. E., and Tansey, M. G. (2009). Does neuroinflammation fan the flame in neurodegenerative diseases? Mol. Neurodegen. 4:47. doi: 10.1186/1750-1326-4-47
55. Fuhrmann, M., Bittner, T., Jung, C. K., Burgold, S., Page, R. M., Mitteregger, G., et al. (2010). Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of alzheimer's disease. Nat. Neurosci. 13, 411-413. doi: 10.1038/nn.2511
56. Galea, I., Bechmann, I., and Perry, V. H. (2007). What is immune privilege (not)? Trends Immunol. 28, 12-18. doi: 10.1016/j.it.2006.11.004
57. Gatto, E. M., Riobó, N. A., Carreras, M. C., Cherñavsky, A., Rubio, A., Satz, M. L., et al. (2000). Overexpression of neutrophil neuronal nitric oxide synthase in parkinson's disease. Nitric Oxide 4, 534-539. doi: 10.1006/niox.2000.0288
58. Gay, F. W., Drye, T. J., Dick, G. W., and Esiri, M. M. (1997). The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. Brain 120(Pt. 8), 1461-1483. doi: 10.1093/brain/120.8.1461
59. Gilgun-Sherki, Y., Melamed, E., and Offen, D. (2001). Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 40, 959-975. doi: 10.1016/s0028-3908(01)00019-3
60. Gonzalez-Cuyar, L. F., Nelson, G., Criswell, S. R., Ho, P., Lonzanida, J. A., Checkoway, H., et al. (2014). Quantitative neuropathology associated with chronic manganese exposure in south african mine workers. Neurotoxicology 45, 260-266. doi: 10.1016/j.neuro.2013.12.008
61. Good, P. F., Hsu, A., Werner, P., Perl, D. P., and Olanow, C. W. (1998). Protein nitration in parkinson's disease. J. Neuropathol. Exp. Neurol. 57, 338-342. doi: 10.1097/00005072-199804000-00006
62. Gu, Z., Nakamura, T., and Lipton, S. A. (2010). Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases. Mol. Neurobiol. 41, 55-72. doi: 10.1007/s12035-010-8113-9
63. Guix, F. X., Uribesalgo, I., Coma, M., and Muñoz, F. J. (2005). The physiology and pathophysiology of nitric oxide in the brain.Prog. Neurobiol. 76, 126-152. doi: 10.1016/j.pneurobio.2005.06.001
64. Guix, F. X., Wahle, T., Vennekens, K., Snellinx, A., Chávez-Gutiérrez, L., Ill-Raga, G., et al. (2012). Modification of gamma-secretase by nitrosative stress links neuronal ageing to sporadic Alzheimer's disease. EMBO Mol. Med. 4, 660-673. doi: 10.1002/emmm.201200243
65. Hattori, Y., Kasai, K., and Gross, S. S. (2004). NO suppresses while peroxynitrite sustains NF-kappaB: a paradigm to rationalize cytoprotective and cytotoxic actions attributed to NO. Cardiovasc. Res. 63, 31-40. doi: 10.1016/j.cardiores.2004.03.014
66. He, Y., Imam, S. Z., Dong, Z., Jankovic, J., Ali, S. F., Appel, S. H., et al. (2003). Role of nitric oxide in rotenone-induced nigro-striatal injury. J. Neurochem. 86, 1338-1345. doi: 10.1046/j.1471-4159.2003.01938.x
67. Horiguchi, T., Uryu, K., Giasson, B. I., Ischiropoulos, H., Lightfoot, R., Bellmann, C., et al. (2003). Nitration of tau protein is linked to neurodegeneration in tauopathies. Am. J. Pathol. 163, 1021-1031. doi: 10.1016/s0002-9440(10)63462-1
68. Huizinga, R., Van Der Star, B. J., Kipp, M., Jong, R., Gerritsen, W., Clarner, T., et al. (2012). Phagocytosis of neuronal debris by microglia is associated with neuronal damage in multiple sclerosis. Glia 60, 422-431. doi: 10.1002/glia.22276
69. Hunot, S., and Hirsch, E. C. (2003). Neuroinflammatory processes in parkinson's disease. Ann. Neurol. 53(Suppl. 3), S49-S58; discussion S58-S60. doi: 10.1002/ana.10481
70. Hurst, R. D., and Fritz, I. B. (1996). Nitric oxide-induced perturbations in a cell culture model of the blood-brain barrier. J. Cell. Physiol. 167, 89-94. doi: 10.1002/(sici)1097-4652(199604)167:1<89::aid-jcp10>3.0.co;2-k
71. Hyun, D. H., Lee, M., Halliwell, B., and Jenner, P. (2003). Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteins. J. Neurochem. 86, 363-373. doi: 10.1046/j.1471-4159.2003.01841.x
72. Ischiropoulos, H., and Beckman, J. S. (2003). Oxidative stress and nitration in neurodegeneration: cause, effect, or association?. J. Clin. Invest. 111, 163-169. doi: 10.1172/jci17638
73. Janigro, D., West, G. A., Nguyen, T. S., and Winn, H. R. (1994). Regulation of blood-brain barrier endothelial cells by nitric oxide. Circ. Res. 75, 528-538. doi: 10.1161/01.res.75.3.528
74. Jekabsone, A., Mander, P. K., Tickler, A., Sharpe, M., and Brown, G. C. (2006). Fibrillar beta-amyloid peptide Abeta1-40 activates microglial proliferation via stimulating TNF-alpha release and H2O2 derived from NADPH oxidase: a cell culture study. J. Neuroinflammation 3:24. doi: 10.1186/1742-2094-3-24
75. Jekabsone, A., Neher, J. J., Borutaite, V., and Brown, G. C. (2007). Nitric oxide from neuronal nitric oxide synthase sensitises neurons to hypoxia-induced death via competitive inhibition of cytochrome oxidase. J. Neurochem. 103, 346-356. doi: 10.1111/j.1471-4159.2007.04765.x
76. Jenner, P. (2003). Oxidative stress in parkinson's disease. Ann. Neurol. 53(Suppl. 3), S26-S36; discussion S36-S28. doi: 10.1002/ana.10483
77. Jimenez, S., Baglietto-Vargas, D., Caballero, C., Moreno-Gonzalez, I., Torres, M., Sanchez-Varo, R., et al. (2008). Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: age-dependent switch in the microglial phenotype from alternative to classic. J. Neurosci. 28, 11650-11661. doi: 10.1523/jneurosci.3024-08.2008
78. Jonnala, R. R., and Buccafusco, J. J. (2001). Inhibition of nerve growth factor signaling by peroxynitrite. J. Neurosci. Res. 63, 27-34. doi: 10.1002/1097-4547(20010101)63:1<27::aid-jnr4>3.3.co;2-r
79. Kanarek, N., London, N., Schueler-Furman, O., and Ben-Neriah, Y. (2010). Ubiquitination and degradation of the inhibitors of NF-kappaB. Cold Spring Harb. Perspect. Biol. 2:a000166. doi: 10.1101/cshperspect.a000166
80. Kashfi, K., and Rigas, B. (2005). Molecular targets of nitric-oxide-donating aspirin in cancer. Biochem. Soc. Trans. 33, 701-704. doi: 10.1042/bst0330701
81. Kato, S., Kato, M., Abe, Y., Matsumura, T., Nishino, T., Aoki, M., et al. (2005). Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS and SOD1-mutated ALS animal models. Acta Neuropathol. 110, 101-112. doi: 10.1007/s00401-005-1019-3
82. Kean, R. B., Spitsin, S. V., Mikheeva, T., Scott, G. S., and Hooper, D. C. (2000). The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the central nervous system in experimental allergic encephalomyelitis through maintenance of blood-central nervous system barrier integrity. J. Immunol. 165, 6511-6518. doi: 10.4049/jimmunol.165.11.6511
83. Kim, H. W., Chang, Y. C., Chen, M., Rapoport, S. I., and Rao, J. S. (2009). Chronic NMDA administration to rats increases brain pro-apoptotic factors while decreasing anti-Apoptotic factors and causes cell death. BMC Neurosci. 10:123. doi: 10.1186/1471-2202-10-123
84. Knott, C., Stern, G., and Wilkin, G. P. (2000). Inflammatory regulators in parkinson's disease: iNOS, lipocortin-1 and cyclooxygenases-1 and -2. Mol. Cell. Neurosci. 16, 724-739. doi: 10.1006/mcne.2000.0914
85. Knowles, R. G., and Moncada, S. (1994). Nitric oxide synthases in mammals. Biochem. J. 298(Pt. 2), 249-258.
86. Kobzik, L., Reid, M. B., Bredt, D. S., and Stamler, J. S. (1994). Nitric oxide in skeletal muscle. Nature 372, 546-548. doi: 10.1038/372546a0
87. Kuhn, D. M., and Geddes, T. J. (2002). Reduced nicotinamide nucleotides prevent nitration of tyrosine hydroxylase by peroxynitrite. Brain Res. 933, 85-89. doi: 10.1016/s0006-8993(02)02307-7
88. Kummer, M. P., Hermes, M., Delekarte, A., Hammerschmidt, T., Kumar, S., Terwel, D., et al. (2011). Nitration of tyrosine 10 critically enhances amyloid beta aggregation and plaque formation. Neuron 71, 833-844. doi: 10.1016/j.neuron.2011.07.001
89. Lambert, J. C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., et al. (2009). Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 41, 1094-1099. doi: 10.1038/ng.439
90. Lee, J. K., Tran, T., and Tansey, M. G. (2009). Neuroinflammation in parkinson's disease. J. Neuroimmune Pharmacol. 4, 419-429. doi: 10.1007/s11481-009-9176-0
91. Li, C., Chen, X., Zhang, N., Song, Y., and Mu, Y. (2012). Gastrodin inhibits neuroinflammation in rotenone-induced parkinson's disease model rats. Neural Regen. Res. 7, 325-331. doi: 10.3969/j.issn.1673-5374.2012.05.001
92. Lipton, S. A. (2007a). Pathologically activated therapeutics for neuroprotection. Nat. Rev. Neurosci. 8, 803-808. doi: 10.1038/nrn2260
93. Lipton, S. A. (2007b). Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation. Curr. Drug Targets 8, 621-632. doi: 10.2174/138945007780618472
94. Lipton, S. A., Choi, Y. B., Pan, Z. H., Lei, S. Z., Chen, H. S., Sucher, N. J., et al. (1993). A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364, 626-632. doi: 10.1038/364626a0
95. Liu, J. S., Zhao, M. L., Brosnan, C. F., and Lee, S. C. (2001). Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am. J. Pathol. 158, 2057-2066. doi: 10.1016/s0002-9440(10)64677-9
96. Loihl, A. K., and Murphy, S. (1998). Expression of nitric oxide synthase-2 in glia associated with CNS pathology. Prog. Brain Res. 118, 253-267. doi: 10.1016/s0079-6123(08)63213-6
97. Long, K., and Nguyen, L. T. (2013). Roles of vitamin D in amyotrophic lateral sclerosis: possible genetic and cellular signaling mechanisms. Mol. Brain 6:16. doi: 10.1186/1756-6606-6-16
98. Lu, F., Selak, M., O'connor, J., Croul, S., Lorenzana, C., Butunoi, C., et al. (2000). Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J. Neurol. Sci. 177, 95-103. doi: 10.1016/s0022-510x(00)00343-9
99. Mancuso, C., Scapagini, G., Curro, D., Giuffrida Stella, A. M., De Marco, C., Butterfield, D. A., et al. (2007). Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. Front. Biosci. 12, 1107-1123. doi: 10.2741/2130
100. Mayhan, W. G. (1999). VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway. Am. J. Physiol. 276, C1148-C1153.
101. McGeer, P. L., Itagaki, S., Akiyama, H., and McGeer, E. G. (1988). Rate of cell death in parkinsonism indicates active neuropathological process. Ann. Neurol. 24, 574-576. doi: 10.1002/ana.410240415
102. McGeer, P. L., and McGeer, E. G. (2007). NSAIDs and alzheimer disease: epidemiological, animal model and clinical studies.Neurobiol. Aging 28, 639-647. doi: 10.1016/j.neurobiolaging.2006.03.013
103. McGeer, P. L., Schwab, C., Parent, A., and Doudet, D. (2003). Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Ann. Neurol. 54, 599-604. doi: 10.1002/ana.10728
104. Mohan, P., Brutsaert, D. L., Paulus, W. J., and Sys, S. U. (1996). Myocardial contractile response to nitric oxide and cGMP.Circulation 93, 1223-1229. doi: 10.1161/01.cir.93.6.1223
105. Mollace, V., Muscoli, C., Masini, E., Cuzzocrea, S., and Salvemini, D. (2005). Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol. Rev. 57, 217-252. doi: 10.1124/pr.57.2.1
106. Mori, F., Fukaya, M., Abe, H., Wakabayashi, K., and Watanabe, M. (2000). Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. Neurosci. Lett. 285, 57-60. doi: 10.1016/s0304-3940(00)01046-6
107. Mosher, K. I., and Wyss-Coray, T. (2014). Microglial dysfunction in brain aging and Alzheimer's disease. Biochem. Pharmacol.88, 594-604. doi: 10.1016/j.bcp.2014.01.008
108. Mosley, R. L., Benner, E. J., Kadiu, I., Thomas, M., Boska, M. D., Hasan, K., et al. (2006). Neuroinflammation, oxidative stress and the pathogenesis of parkinson's disease. Clin. Neurosci. Res. 6, 261-281. doi: 10.1016/j.cnr.2006.09.006
109. Murray, J., Taylor, S. W., Zhang, B., Ghosh, S. S., and Capaldi, R. A. (2003). Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry. J. Biol. Chem. 278, 37223-37230. doi: 10.1074/jbc.m305694200
110. Nakagawa, T., and Yokozawa, T. (2002). Direct scavenging of nitric oxide and superoxide by green tea. Food Chem. Toxicol.40, 1745-1750. doi: 10.1016/s0278-6915(02)00169-2
111. Nakamura, T., and Lipton, S. A. (2011). S-nitrosylation of critical protein thiols mediates protein misfolding and mitochondrial dysfunction in neurodegenerative diseases. Antioxid. Redox Signal. 14, 1479-1492. doi: 10.1089/ars.2010.3570
112. Nikić, I., Merkler, D., Sorbara, C., Brinkoetter, M., Kreutzfeldt, M., Bareyre, F. M., et al. (2011). A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat. Med. 17, 495-499. doi: 10.1038/nm.2324
113. Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., et al. (2001). Oxidative damage is the earliest event in alzheimer disease. J. Neuropathol. Exp. Neurol. 60, 759-767.
114. Ozawa, K., Whalen, E. J., Nelson, C. D., Mu, Y., Hess, D. T., Lefkowitz, R. J., et al. (2008). S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking. Mol. Cell 31, 395-405. doi: 10.1016/j.molcel.2008.05.024
115. Pacher, P., Beckman, J. S., and Liaudet, L. (2007). Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315-424. doi: 10.1152/physrev.00029.2006
116. Palmer, R. M., Ferrige, A. G., and Moncada, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327, 524-526. doi: 10.1038/327524a0
117. Pehar, M., Vargas, M. R., Robinson, K. M., Cassina, P., England, P., Beckman, J. S., et al. (2006). Peroxynitrite transforms nerve growth factor into an apoptotic factor for motor neurons. Free Radic. Biol. Med. 41, 1632-1644. doi: 10.1016/j.freeradbiomed.2006.08.010
118. Peluffo, H., Shacka, J. J., Ricart, K., Bisig, C. G., Martìnez-Palma, L., Pritsch, O., et al. (2004). Induction of motor neuron apoptosis by free 3-nitro-L-tyrosine. J. Neurochem. 89, 602-612. doi: 10.1046/j.1471-4159.2004.02363.x
119. Petković, F., Blaževski, J., Momčilović, M., Mostarica Stojkovic, M., and Miljković, D. (2013). Nitric oxide inhibits CXCL12 expression in neuroinflammation. Immunol. Cell Biol. 91, 427-434. doi: 10.1038/icb.2013.23
120. Picconi, B., Centonze, D., Rossi, S., Bernardi, G., and Calabresi, P. (2004). Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism. Brain127, 1661-1669. doi: 10.1093/brain/awh190
121. Rao, J. S., Ertley, R. N., Rapoport, S. I., Bazinet, R. P., and Lee, H. J. (2007). Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2. J. Neurochem. 102, 1918-1927. doi: 10.1111/j.1471-4159.2007.04648.x
122. Rao, J. S., Harry, G. J., Rapoport, S. I., and Kim, H. W. (2010). Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol. Psychiatry 15, 384-392. doi: 10.1038/mp.2009.47
123. Rao, J. S., Kellom, M., Kim, H. W., Rapoport, S. I., and Reese, E. A. (2012). Neuroinflammation and synaptic loss. Neurochem. Res. 37, 903-910. doi: 10.1007/s11064-012-0708-2
124. Ratai, E. M., Annamalai, L., Burdo, T., Joo, C. G., Bombardier, J. P., Fell, R., et al. (2011). Brain creatine elevation and N-acetylaspartate reduction indicates neuronal dysfunction in the setting of enhanced glial energy metabolism in a macaque model of neuroAIDS. Magn. Reson. Med. 66, 625-634. doi: 10.1002/mrm.22821
125. Reaume, A. G., Elliott, J. L., Hoffman, E. K., Kowall, N. W., Ferrante, R. J., Siwek, D. F., et al. (1996). Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 13, 43-47. doi: 10.1038/ng0596-43
126. Redford, E. J., Kapoor, R., and Smith, K. J. (1997). Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 120, 2149-2157. doi: 10.1093/brain/120.12.2149
127. Reynolds, M. R., Reyes, J. F., Fu, Y., Bigio, E. H., Guillozet-Bongaarts, A. L., Berry, R. W., et al. (2006). Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies. J. Neurosci. 26, 10636-10645. doi: 10.1523/jneurosci.2143-06.2006
128. Rothstein, J. D. (2009). Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann. Neurol. 65, (Suppl. 1), S3-S9. doi: 10.1002/ana.21543
129. Saha, R. N., and Pahan, K. (2006). Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid. Redox Signal. 8, 929-947. doi: 10.1089/ars.2006.8.929
130. Sartoretto, J. L., Kalwa, H., Pluth, M. D., Lippard, S. J., and Michel, T. (2011). Hydrogen peroxide differentially modulates cardiac myocyte nitric oxide synthesis. Proc. Natl. Acad. Sci. U S A 108, 15792-15797. doi: 10.1073/pnas.1111331108
131. Sasaki, N., Yamashita, T., Takaya, T., Shinohara, M., Shiraki, R., Takeda, M., et al. (2008). Augmentation of vascular remodeling by uncoupled endothelial nitric oxide synthase in a mouse model of diabetes mellitus. Arterioscler. Thromb. Vasc. Biol. 28, 1068-1076. doi: 10.1161/atvbaha.107.160754
132. Silvestroni, A., Faull, R. L., Strand, A. D., and Möller, T. (2009). Distinct neuroinflammatory profile in post-mortem human huntington's disease. Neuroreport 20, 1098-1103. doi: 10.1097/wnr.0b013e32832e34ee
133. Simard, M., and Nedergaard, M. (2004). The neurobiology of glia in the context of water and ion homeostasis. Neuroscience129, 877-896. doi: 10.1016/j.neuroscience.2004.09.053
134. Singel, D. J., and Stamler, J. S. (2005). Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin. Annu. Rev. Physiol. 67, 99-145. doi: 10.1146/annurev.physiol.67.060603.090918
135. Singh, S., Das, T., Ravindran, A., Chaturvedi, R. K., Shukla, Y., Agarwal, A. K., et al. (2005). Involvement of nitric oxide in neurodegeneration: a study on the experimental models of parkinson's disease. Redox Rep. 10, 103-109. doi: 10.1179/135100005x38842
136. Smith, K. J., and Lassmann, H. (2002). The role of nitric oxide in multiple sclerosis. Lancet Neurol. 1, 232-241. doi: 10.1016/s1474-4422(02)00102-3
137. Souza, J. M., Giasson, B. I., Chen, Q., Lee, V. M., and Ischiropoulos, H. (2000). Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J. Biol. Chem. 275, 18344-18349. doi: 10.1074/jbc.m000206200
138. Spiegel, S., and Milstien, S. (2011). The outs and the ins of sphingosine-1-phosphate in immunity. Nat. Rev. Immunol. 11, 403-415. doi: 10.1038/nri2974
139. Spitsin, S. V., Scott, G. S., Kean, R. B., Mikheeva, T., and Hooper, D. C. (2000). Protection of myelin basic protein immunized mice from free-radical mediated inflammatory cell invasion of the central nervous system by the natural peroxynitrite scavenger uric acid. Neurosci. Lett. 292, 137-141. doi: 10.1016/s0304-3940(00)01446-4
140. Spuch, C., Ortolano, S., and Navarro, C. (2012). New insights in the amyloid-beta interaction with mitochondria. J. Aging Res.2012:324968. doi: 10.1155/2012/324968
141. Stamler, J. S., Lamas, S., and Fang, F. C. (2001). Nitrosylation. the prototypic redox-based signaling mechanism. Cell 106, 675-683. doi: 10.1016/S0092-8674(01)00495-0
142. Stamler, J. S., Toone, E. J., Lipton, S. A., and Sucher, N. J. (1997). (S)NO signals: translocation, regulation and a consensus motif. Neuron 18, 691-696. doi: 10.1016/s0896-6273(00)80310-4
143. Sunico, C. R., Nakamura, T., Rockenstein, E., Mante, M., Adame, A., Chan, S. F., et al. (2013). S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic parkinson's disease. Mol. Neurodegener. 8:29. doi: 10.1186/1750-1326-8-29
144. Swerdlow, R. H. (2011). Brain aging, Alzheimer's disease and mitochondria. Biochim. Biophys. Acta 1812, 1630-1639. doi: 10.1016/j.bbadis.2011.08.012
145. Thiabaud, G., Pizzocaro, S., Garcia-Serres, R., Latour, J. M., Monzani, E., and Casella, L. (2013). Heme binding induces dimerization and nitration of truncated beta-amyloid peptide Abeta16 under oxidative stress. Angew. Chem. Int. Ed. Engl. 52, 8041-8044. doi: 10.1002/anie.201302989
146. Tipton, K. F. (1967). The sub-mitochondrial localization of monoamine oxidase in rat liver and brain. Biochim. Biophys. Acta135, 910-920. doi: 10.1016/0005-2736(67)90060-0
147. Wahner, A. D., Bronstein, J. M., Bordelon, Y. M., and Ritz, B. (2007). Nonsteroidal anti-inflammatory drugs may protect against parkinson disease. Neurology 69, 1836-1842. doi: 10.1212/01.wnl.0000279519.99344.ad
148. Wang, H., and Pickel, V. M. (2002). Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus. J. Comp. Neurol. 442, 392-404. doi: 10.1002/cne.10086
149. Wilkinson, B. L., and Landreth, G. E. (2006). The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease. J. Neuroinflammation 3:30. doi: 10.1186/1742-2094-3-30
150. Wilms, H., Zecca, L., Rosenstiel, P., Sievers, J., Deuschl, G., and Lucius, R. (2007). Inflammation in parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications. Curr. Pharm. Des. 13, 1925-1928. doi: 10.2174/138161207780858429
151. Winkler, F., Koedel, U., Kastenbauer, S., and Pfister, H. W. (2001). Differential expression of nitric oxide synthases in bacterial meningitis: role of the inducible isoform for blood-brain barrier breakdown. J. Infect. Dis. 183, 1749-1759. doi: 10.1086/320730
152. Wu, M., and Tsirka, S. E. (2009). Endothelial NOS-deficient mice reveal dual roles for nitric oxide during experimental autoimmune encephalomyelitis. Glia 57, 1204-1215. doi: 10.1002/glia.20842
153. Xia, Y., Tsai, A. L., Berka, V., and Zweier, J. L. (1998). Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J. Biol. Chem. 273, 25804-25808. doi: 10.1074/jbc.273.40.25804
154. Xie, X., Wang, H.-T., Li, H.-L., Gao, X.-H., Ding, J., Zhao, H.-H., et al. (2010). Ginsenoside Rb1 protects PC12 cells against β-amyloid-induced cell injury. Mol. Med. Rep. 3, 635-639. doi: 10.3892/mmr_00000308
155. Xu, L., Eu, J. P., Meissner, G., and Stamler, J. S. (1998). Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279, 234-237. doi: 10.1126/science.279.5348.234
156. Yoshino, H., and Kimura, A. (2006). Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study). Amyotroph. Lateral Scler. 7, 241-245. doi: 10.1080/17482960600881870
157. Zecca, L., Wilms, H., Geick, S., Claasen, J. H., Brandenburg, L. O., Holzknecht, C., et al. (2008). Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for parkinson's disease. Acta Neuropathol.116, 47-55. doi: 10.1007/s00401-008-0361-7
158. Zhang, L., Dawson, V. L., and Dawson, T. M. (2006). Role of nitric oxide in parkinson's disease. Pharmacol. Ther. 109, 33-41. doi: 10.1016/j.pharmthera.2005.05.007
159. Zhang, B., Gaiteri, C., Bodea, L. G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., et al. (2013). Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell 153, 707-720. doi: 10.1016/j.cell.2013.03.030
160. Zielasek, J., Reichmann, H., Künzig, H., Jung, S., Hartung, H. P., and Toyka, K. V. (1995). Inhibition of brain macrophage/microglial respiratory chain enzyme activity in experimental autoimmune encephalomyelitis of the lewis rat.Neurosci. Lett. 184, 129-132. doi: 10.1016/0304-3940(94)11187-n